Luteinizing hormone-releasing hormone agonists in prostate cancer. Elimination of flare reaction by pretreatment with cyproterone acetate and low-dose diethylstilbestrol
- 1 September 1993
- Vol. 72 (5) , 1685-1691
- https://doi.org/10.1002/1097-0142(19930901)72:5<1685::aid-cncr2820720532>3.0.co;2-3
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Sudden Death due to Disease Flare with Luteinizing Hormone-Releasing Hormone Agonist Therapy for Carcinoma of the ProstateJournal of Urology, 1990
- Influence of Different Types of Antiandrogens on Luteinizing Hormone-Releasing Hormone Analogue-Induced Testosterone Surge in Patients with Metastatic Carcinoma of the ProstateJournal of Urology, 1990
- A Controlled Trial of Leuprolide with and without Flutamide in Prostatic CarcinomaNew England Journal of Medicine, 1989
- Prevention of the Transient Adverse Effects of a Gonadotropin-Releasing Hormone Analogue (Buserelin) in Metastatic Prostatic Carcinoma by Administration of an Antiandrogen (Nilutamide)New England Journal of Medicine, 1989
- Can combined des and lhrh depot therapy (ICI 118630) prevent endocrinologic and clinical flare-up in metastatic prostate cancer?Urology, 1988
- The Effect of Nafarelin Acetate, a Luteinizing-Hormone–Releasing Hormone Agonist, on Benign Prostatic HyperplasiaNew England Journal of Medicine, 1987
- Kinetic evaluation of the effect of LHRH analog on prostatic cancer using transrectal ultrasonotomographyThe Prostate, 1987
- Importance of early tumour exacerbation in patients treated with long acting analogues of gonadotrophin releasing hormone for advanced prostatic cancer.BMJ, 1985
- Des lead-in to use of luteinizing hormone releasing hormone analogs in treatment of metastatic carcinoma of prostateUrology, 1985
- Leuprolide versus Diethylstilbestrol for Metastatic Prostate CancerNew England Journal of Medicine, 1984